Concepedia

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants

Shô Miyamoto, Takeshi Arashiro, Yu Adachi, Saya Moriyama, Hitomi Kinoshita, Takayuki Kanno, Shinji Saito, Harutaka Katano, Shun Iida, Akira Ainai,

Med · 2022 · 78 citations · 27 references

DOIFull text

Open access

Concepts

References

27

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Lihong Liu, Sho Iketani, Yicheng Guo et al. · Nature · 2021 · 1.4K citations · Full text

, , +13

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Shuo Feng, Daniel J. Phillips, Thomas White et al. · Nature Medicine · 2021 · 1.2K citations · Full text

, , +17

Correlates of protection against SARS-CoV-2 in rhesus macaques

Katherine McMahan, Jingyou Yu, Noe B. Mercado et al. · Nature · 2020 · 1.2K citations · Full text

, , +12

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

, , +16

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Elisabetta Cameroni, John E. Bowen, Laura E. Rosen et al. · Nature · 2021 · 1.2K citations · Full text

, , +14